Načítá se...
Candidate drug replacements for quinacrine in cutaneous lupus erythematosus
Cutaneous lupus erythematosus (CLE) is a disfiguring and potentially disabling disease that causes significant morbidity in patients. Antimalarials are an important class of medication used to treat this disease and have been the first-line systemic therapy since the 1950s. Quinacrine, in particular...
Uloženo v:
| Vydáno v: | Lupus Sci Med |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7577055/ https://ncbi.nlm.nih.gov/pubmed/33082164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/lupus-2020-000430 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|